Q32 Bio Inc. (QTTB) EBT (2017 - 2026)

Q32 Bio has reported EBT for 10 years, with the latest figure at -$9.1 million in Q2 2026.

• On a quarterly basis, EBT rose 3.91% year-over-year to -$9.1 million in Q2 2026; TTM through Jun 2026 was $33.5 million, a 164.08% increase from a year earlier, with the FY2025 full-year figure at $29.8 million, up 164.71% from the prior year.
• EBT was -$9.1 million for Q2 2026 at Q32 Bio, down from -$7.7 million in the prior quarter.
• The five-year high for EBT was $93.7 million in Q1 2022, with the low at -$33.0 million in Q4 2022.
• Average EBT over 5 years is -$4.7 million, with a median of -$10.3 million recorded in 2025.
• The sharpest annual moves came in 2022 and 2025: EBT surged 8829.08% in 2022, then slumped 1015.44% in 2025.
• Over 5 years, EBT stood at -$33.0 million in 2022, then gained by 18.84% to -$26.8 million in 2023, then surged by 47.16% to -$14.2 million in 2024, then surged by 507.47% to $57.7 million in 2025, then slumped by 115.79% to -$9.1 million in 2026.
• The last three EBT figures came in at -$9.1 million (Q2 2026), -$7.7 million (Q1 2026), and $57.7 million (Q4 2025), per Business Quant data.